GoodRx Holdings, Inc.
Company Stats
- Market Cap
- $1.1B
- as of Sep 30, 2026
- Shares Outstanding
- 341.1M
- Free Float
- 12.6%
Income Statement
- Revenue
- $796.9M
- Operating Income
- $87.5M
- Net Income
- $30.4M
- EBITDA
- $91.7M
- Revenue Growth, 3Y
- 1.3%
- FCF Margin, 3Y Avg
- 20.7%
- FCF Margin, Worst Year
- 18.3%
Cash Flow
- Free Cash Flow
- $164.4M
- FCF Yield
- 14.6%
- Owner FCF Yield
- 7.8%
Balance Sheet
- Cash & Equivalents
- $261.8M
Returns & Capital
- Share Repurchases
- $216.4M
- Buyback Yield, 3Y Avg
- 14.2%
- SBC, 3Y Avg
- $93.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $796.9M | $164.4M | 20.6% |
| FY2024 | $792.3M | $182.7M | 23.1% |
| FY2023 | $750.3M | $137.2M | 18.3% |
| FY2022 | $766.6M | $142.8M | 18.6% |
| FY2021 | $745.4M | $174.2M | 23.4% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 14, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Aci Lifts 2026 Guidance as Software Demand Stays Positive
Stronger demand supports expansion as pricing diverges